Medtronic TAV
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Medtronic Cardiovascular
Overview
Medtronic TAV is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Medtronic TAV clinical trials
Explore related
Medical disclaimer. This page summarizes research about Medtronic TAV for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.